Real-world multicentre cohort of first-line pembrolizumab alone or in combination with platinum-based chemotherapy in non-small cell lung cancer PD-L1 ≥ 50%
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
Real-world multicentre cohort of first-line pembrolizumab alone or in combination with platinum-based chemotherapy in non-small cell lung cancer PD-L1 ≥ 50% ; volume:72 ; number:6 ; day:24 ; month:1 ; year:2023 ; pages:1881-1890 ; date:6.2023
Cancer immunology immunotherapy ; 72, Heft 6 (24.1.2023), 1881-1890, 6.2023
- Urheber
-
Pons-Tostivint, E.
Hulo, P.
Guardiolle, V.
Bodot, L.
Rabeau, A.
Porte, M.
Hiret, S.
Demontrond, P.
Curcio, H.
Boudoussier, A.
Veillon, R.
Mayenga, M.
Dumenil, C.
Chatellier, T.
Gourraud, P. A.
Mazieres, J.
Bennouna, J.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00262-022-03359-2
- URN
-
urn:nbn:de:101:1-2023090911380300075122
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:48 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Pons-Tostivint, E.
- Hulo, P.
- Guardiolle, V.
- Bodot, L.
- Rabeau, A.
- Porte, M.
- Hiret, S.
- Demontrond, P.
- Curcio, H.
- Boudoussier, A.
- Veillon, R.
- Mayenga, M.
- Dumenil, C.
- Chatellier, T.
- Gourraud, P. A.
- Mazieres, J.
- Bennouna, J.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Correction to: Real-world multicentre cohort of first-line pembrolizumab alone or in combination with platinum-based chemotherapy in non-small cell lung cancer PD-L1 ≥ 50%
Endostar plus pembrolizumab combined with a platinum-based dual chemotherapy regime for advanced pulmonary large-cell neuroendocrine carcinoma as a first-line treatment: A case report
PD-L1 and MRN synergy in platinum-based chemoresistance of head and neck squamous cell carcinoma
Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-based chemotherapy: the ARON-2 study
The effectiveness and safety of platinum-based pemetrexed and platinum-based gemcitabine treatment in patients with malignant pleural mesothelioma
Ototoxicity and Platinum Uptake Following Cyclic Administration of Platinum-Based Chemotherapeutic Agents
First-line treatment for patients with advanced non-small cell lung carcinoma and high PD-L1 expression: pembrolizumab or pembrolizumab plus chemotherapy
Pembrolizumab with platinum-based chemotherapy with or without epacadostat as first-line treatment for metastatic non-small cell lung cancer: a randomized, partially double-blind, placebo-controlled phase II study
Platinum-based chemotherapy in metastatic prostate cancer: what possibilities?
Speciation analysis of platinum-based chemotherapy drugs in human blood
The interactions of novel mononuclear platinum-based complexes with DNA
Electrolyte disorders with platinum-based chemotherapy: mechanisms, manifestations and management
Correction to: Real-world multicentre cohort of first-line pembrolizumab alone or in combination with platinum-based chemotherapy in non-small cell lung cancer PD-L1 ≥ 50%
Endostar plus pembrolizumab combined with a platinum-based dual chemotherapy regime for advanced pulmonary large-cell neuroendocrine carcinoma as a first-line treatment: A case report
PD-L1 and MRN synergy in platinum-based chemoresistance of head and neck squamous cell carcinoma
Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-based chemotherapy: the ARON-2 study
The effectiveness and safety of platinum-based pemetrexed and platinum-based gemcitabine treatment in patients with malignant pleural mesothelioma
Ototoxicity and Platinum Uptake Following Cyclic Administration of Platinum-Based Chemotherapeutic Agents
First-line treatment for patients with advanced non-small cell lung carcinoma and high PD-L1 expression: pembrolizumab or pembrolizumab plus chemotherapy
Pembrolizumab with platinum-based chemotherapy with or without epacadostat as first-line treatment for metastatic non-small cell lung cancer: a randomized, partially double-blind, placebo-controlled phase II study
Platinum-based chemotherapy in metastatic prostate cancer: what possibilities?
Speciation analysis of platinum-based chemotherapy drugs in human blood
The interactions of novel mononuclear platinum-based complexes with DNA
Electrolyte disorders with platinum-based chemotherapy: mechanisms, manifestations and management
Correction to: Real-world multicentre cohort of first-line pembrolizumab alone or in combination with platinum-based chemotherapy in non-small cell lung cancer PD-L1 ≥ 50%
Endostar plus pembrolizumab combined with a platinum-based dual chemotherapy regime for advanced pulmonary large-cell neuroendocrine carcinoma as a first-line treatment: A case report
PD-L1 and MRN synergy in platinum-based chemoresistance of head and neck squamous cell carcinoma
Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-based chemotherapy: the ARON-2 study
The effectiveness and safety of platinum-based pemetrexed and platinum-based gemcitabine treatment in patients with malignant pleural mesothelioma
Ototoxicity and Platinum Uptake Following Cyclic Administration of Platinum-Based Chemotherapeutic Agents
First-line treatment for patients with advanced non-small cell lung carcinoma and high PD-L1 expression: pembrolizumab or pembrolizumab plus chemotherapy
Pembrolizumab with platinum-based chemotherapy with or without epacadostat as first-line treatment for metastatic non-small cell lung cancer: a randomized, partially double-blind, placebo-controlled phase II study
Platinum-based chemotherapy in metastatic prostate cancer: what possibilities?
Speciation analysis of platinum-based chemotherapy drugs in human blood
The interactions of novel mononuclear platinum-based complexes with DNA